Picture EBD Group World of Partnering Opportunities 650x100px

Organisation › Details

WuXi AppTec Corporate Ventures

	Start	2018-05-16 existent
	Group	WuXi PharmaTech (Group)
	Industry	venture capital
	Industry 2	LIFE SCIENCES

	City	n. a.
		Address record changed: 2018-05-22

Basic data	Employees	n. a.


		Record changed: 2020-08-04

Picture Berlin Partner Top News Healthtech Company Mika 650x200px

More documents for WuXi PharmaTech (Group)

[1] WuXi Biologics. (1/11/24). "Press Release: WuXi Biologics Announces Research Service Agreement with BioNTech on Discovering Investigational Monoclonal Antibodies for Developing Next-Generation Therapeutic Product Candidates". Shanghai....
[2] Bristol-Myers Squibb Company. (8/3/21). "Press Release: Bristol Myers Squibb Completes Sale of Manufacturing Facility in Couvet, Switzerland". New York, NY....
[3] Metrion Biosciences Ltd.. (7/26/21). "Press Release: Metrion Biosciences Appoints Nick Foster as Chief Commercial Officer and Head of Global Business Development". Cambridge....
[4] WuXi AppTec. (7/20/21). Web Page: WuXi Global Forum 2021. [https://www.wuxiapptec.com, 07/20/21]...
[5] WuXi AppTec. (7/20/21). Web Page: WuXi Healthcare Forum 2021. [https://www.wuxiapptec.com, 07/20/21]...
[6] Oxford Genetics Ltd.. (3/2/21). "Press Release: WuXi AppTec Completes Acquisition of Oxgene to Further Strengthen Cell and Gene Therapy Service Offerings for Global Customers". Philadeliphia, PA & Oxford....
[7] Quanterix Corporation. (2/12/21). "Press Release: Quanterix Announces Simoa Joint Laboratory with WuXi AppTec". Billerica, MA....
[8] Almirall S.A.. (1/9/20). "Press Release: Almirall and WuXi Biologics Sign Strategic Collaboration Agreement for Multiple Bispecific Antibodies Targeting Dermatology Diseases". Barcelona....
[9] AC Immune S.A.. (12/19/18). "Press Release: AC Immune and WuXi Biologics to Establish an Exclusive Strategic Partnership". Lausanne & Shanghai....
[10] Oxford BioTherapeutics Ltd.. (12/11/18). "Press Release: Oxford BioTherapeutics Expands Strategic Collaboration with WuXi Biologics and Licenses WuXiBody Platform for Five Bispecific Antibody Programs for up to $450 Million". Shanghai & Oxford....

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]